Exploring the Impact of Immunotherapy on Cancer Recurrence

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

Amruta Dadasaheb Kalunkhe; Dr.Vaishali Pardeshi; Dr.Sonia Singh; Dr.Ganesh Andhale; Dr.Madhuri Shelar

Exploring the Impact of Immunotherapy on Cancer Recurrence

Authors: Amruta Dadasaheb Kalunkhe, Dr.Vaishali Pardeshi, Dr.Sonia Singh, Dr.Ganesh Andhale, Dr.Madhuri Shelar

Unique Paper ID: 176384
Volume: 11
Issue: 11
PageNo: 6229-6234

Keywords: Active immunotherapy passive Immunotherapy Adaptive cell therapy cancer immunotherapy cancer vaccines.

Abstract:
The body's inherent defenses against cancer were known long before the modern era, as evidenced by numerous anecdotal accounts of tumors magically vanishing, sometimes on their own or following an infectious or feverish event. It is now widely acknowledged that immunosuppression is linked to an increased risk of cancer, and spontaneous tumor regression of untreated malignant tumors is a rare but well-accepted phenomena.Biologic modifiers, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, and antibodies against immune checkpoint inhibitors, such as the co-inhibitory T-cell receptor PD-1 and one of its ligands, programmed death-ligand 1, are among the various forms of cancer immunotherapies covered here.(1) As a result of the tremendous advancements in cancer research over the years, immunotherapy has become a significant cancer therapies. Immunotherapy has shown promising results and presents a practical approach to significantly increase the overall survival rate of cancer patients while also improving their quality of life. This systematic review's goal was to evaluate immunotherapy's effectiveness in treating cancer.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 11
PageNo: 6229-6234

Exploring the Impact of Immunotherapy on Cancer Recurrence

Available:https://ijirt.org/article?manuscript=176384

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now